Drugs.com Newsletter Archive

Our popular newsletter containing a regular roundup of medication news, alerts and new drug approvals.

Archive

Recently Approved

Ontruzant Ontruzant (trastuzumab-dttb) is a HER2 / neu receptor antagonist biosimilar to...
Ultomiris Ultomiris (ravulizumab-cwvz) is a long-acting C5 complement inhibitor for the...
Elzonris Elzonris (tagraxofusp-erzs) is a CD123-directed cytotoxin for the treatment of...
ProAir Digihaler ProAir Digihaler (albuterol sulfate) is a beta2-adrenergic agonist indicated...

More approvals

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated Dec 6th, 2018), Cerner Multum™ (updated Dec 7th, 2018), Wolters Kluwer™ (updated Dec 5th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.

Drugs.com Newsletter Archive

Archive

Support

About

Terms & Privacy

Drugs.com Newsletter Archive

Archive

Drugs.com Mobile Apps

Support

About

Terms & Privacy